![Eric Aguiar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Aguiar
Director/Board Member at
BIOMEA FUSION, INC.
Net worth: 787 924 $ as of 30/06/2026
Profile
Dr. Eric I.
Aguiar is a Lead Independent Director at Biomea Fusion, Inc., an Independent Director at BridgeBio Pharma, Inc., a Partner at Aisling Capital LLC, a Council Member at Tufts University School of Medicine and a Member at Council on Foreign Relations, Inc. He is on the Board of Directors at Biomea Fusion, Inc., BridgeBio Pharma LLC, BridgeBio Pharma, Inc. and Stratus Therapeutics, Inc. Dr. Aguiar was previously employed as an Independent Director by Eidos Therapeutics, Inc., an Independent Director by Biohaven Pharmaceutical Holding Co. Ltd., a Lead Independent Director by Invitae Corp., a Non-Executive Director by Amarin Corp.
Plc, a Partner by Thomas, McNerney & Partners LLC, a Managing Director by HealthCare Ventures LLC, a Chief Executive Officer & Director by Genovo, Inc., a Vice President & Managing Director by Philadelphia Ventures, Inc., an Independent Director by Oriel Therapeutics, Inc., and an Executive Director by TheraTech, Inc. He also served on the board at Biohaven Research Ltd., 3-Dimensional Pharmaceuticals, Inc., Amarin Pharmaceuticals, Inc., CardioKine, Inc., Intuity Medical, Inc., Locus Development, Inc., Metaphore Pharmaceuticals, Inc., SkinMedica, Inc., VaxInnate Corp.
and Virdante Pharmaceuticals, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/06/2026 | 10,579 ( 0.01% ) | 787 924 $ | 30/06/2026 | |
BIOMEA FUSION INC -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Eric Aguiar active positions
| Companies | Position | Start |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Director/Board Member | 01/03/2019 |
| BIOMEA FUSION, INC. | Director/Board Member | 01/12/2020 |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Director/Board Member | - |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology Discovers and develops medicines for patients with genetic diseases | Director/Board Member | 01/03/2019 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Private Equity Investor | 01/01/2016 |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
Former positions of Eric Aguiar
| Companies | Position | End |
|---|---|---|
| INVITAE CORPORATION | Chairman | - |
| EIDOS THERAPEUTICS, INC. | Director/Board Member | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of Eric Aguiar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
29
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 29 |
|---|---|
TheraTech, Inc.
 TheraTech, Inc. Medical DistributorsDistribution Services Manufactures and distributes medical devices | Distribution Services |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and discovers drug candidates using its accelerated methodology for small molecule drug discovery | Health Technology |
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Health Technology |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
SkinMedica, Inc.
 SkinMedica, Inc. Medical DistributorsDistribution Services Develops dermatology products | Distribution Services |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Virdante Pharmaceuticals, Inc.
 Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops and commercializes drugs | Distribution Services |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Genovo, Inc.
 Genovo, Inc. Medical SpecialtiesHealth Technology Maker of gene and cell therapy products | Health Technology |
Amarin Pharmaceuticals, Inc.
 Amarin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Finance |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and market drugs | Health Technology |
Council on Foreign Relations, Inc.
Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
Intuity Medical, Inc.
 Intuity Medical, Inc. Medical SpecialtiesHealth Technology Develops blood glucose monitoring system for diabetic patients | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Locus Development, Inc.
 Locus Development, Inc. Real Estate DevelopmentFinance Provides real estate development and asset management services | Finance |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology Discovers and develops medicines for patients with genetic diseases | Health Technology |
Philadelphia Ventures, Inc.
 Philadelphia Ventures, Inc. Investment ManagersFinance Philadelphia Ventures invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors. It provides financing for early stage transactions. | Finance |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Eric Aguiar
